Viral Hepatitis Research Laboratory, Beijing Institute of Infectious Diseases, Beijing 100039, China.
J Gastroenterol. 2011 Mar;46(3):391-400. doi: 10.1007/s00535-010-0315-4. Epub 2010 Sep 17.
To investigate the features of hepatitis B virus (HBV) basal core promoter/precore (BCP/PC) mutations and genotypes in a large number of mild/severe chronic hepatitis B (CHB-M/CHB-S), and acute-on-chronic liver failure (ACLF) patients and analyze the clinical implications of the virologic features.
Sera of 793 (325 CHB-M, 170 CHB-S, and 298 ACLF) patients admitted to or who had visited Beijing 302 Hospital from January 2005 to December 2008 were collected and successfully amplified for the HBV BCP/PC and a 1225-bp-long S/Pol (nt 54-1278) gene regions. Biochemical and serological parameters and HBV DNA level were routinely performed. Viral DNA was extracted and subjected to a nested PCR. Genotypes/subgenotypes were determined based on complete genomic sequence or on analysis of the 1225-bp-long S/Pol-gene sequence. HBV genotyping was performed by direct PCR sequencing followed by molecular evolutionary analysis of the viral sequences. A P value of <0.05 (two-sided) was considered to be statistically significant.
Our findings suggest that CHB patients infected with BCP/PC mutant viruses are more susceptible to severe hepatitis and ACLF than those with the BCP/PC wild-type virus and that ACLF patients with PC mutant viruses have an increased risk of death. As such, the HBV PC mutation is a potential predictive indicator of ACLF outcome.
研究大量轻度/重度慢性乙型肝炎(CHB-M/CHB-S)和慢加急性肝衰竭(ACLF)患者乙型肝炎病毒(HBV)基本核心启动子/前核心(BCP/PC)突变和基因型的特征,并分析病毒学特征的临床意义。
收集 2005 年 1 月至 2008 年 12 月期间在北京 302 医院就诊或就诊的 793 例(325 例 CHB-M、170 例 CHB-S 和 298 例 ACLF)患者的血清,成功扩增了 HBV BCP/PC 和 1225 个碱基长的 S/Pol(nt54-1278)基因区域。常规进行生化和血清学参数以及 HBV DNA 水平检测。提取病毒 DNA,进行巢式 PCR。根据完整基因组序列或 1225 个碱基长的 S/Pol 基因序列分析确定基因型/亚型。通过直接 PCR 测序进行 HBV 基因分型,然后对病毒序列进行分子进化分析。P 值<0.05(双侧)被认为具有统计学意义。
我们的研究结果表明,与野生型 BCP/PC 病毒相比,感染 BCP/PC 突变病毒的 CHB 患者更容易发生重型肝炎和 ACLF,而感染 PC 突变病毒的 ACLF 患者死亡风险增加。因此,HBV PC 突变是 ACLF 预后的一个潜在预测指标。